Our website is set to 'allow cookies' to give you the best experience without telling us who you are. Please continue if you consent to this, or click below to change your settings:
Find out more about our cookies policy
(+1) 617 896 0213
info@sagentia.com
Following the recent approval by the FDA of the over-the-counter Cynosure device for treating facial wrinkles, Sagentia's Peter Luebcke discusses the benefits of CPG companies positioning their devices as medical rather than cosmetic devices. » Read more
Tags: personal care diagnostic devices, brand bundle,
Fabien Schmitt, Consultant at Sagentia Ltd., reflects on the trend towards the delivery of healthcare through smartphone mobile apps, prompted by an article published on FierceMedicalDevices. » Read more
Tags: apps, healthcare, innovation, smartphone.
How can regulatory requirements governing medical devices be reconciled with the fast and furious pace of app development? Sagentia's Dr. Paulo Pinheiro comments on an article published by EMDT online. » Read more
Tags: regulation, medical, apps
Following a recent article in The Daily Telegraph Sagentia responds to the news that 9 out of every 10 asthma deaths could be preventable if suffers use drug delivery devices correctly. » Read more
Tags: drug delivery, inhaler, usability
Niall Mottram, Sagentia's US Head of ITM, reflects on the topics being explored at the 2012 Front End of Innovation event in Orlando.
Tags: FEI, front end innovation
Experts in complex science & technology Multidisciplinary, cross sector team approach Excel at meeting aggressive timescales Customer friendly approach to IP Accreditation to ISO9001:2008 and ISO13485:2003 What our clients say: "We have worked with Sagentia on a number of issues. The reason in every case is their ability to deliver innovative engineering and then deliver on execution."
Keep track of site upates using our RSS feeds, click a link below to view the feed.